Previous Page
Nanologica AB announced that Sören Gyll, Gisela Sitbon and Todd Ashton have joined the company’s board after a vote during the annual shareholder’s meeting. Sören Gyll is one of Sweden’s most renowned business leaders and has, among other things, been CEO at Volvo. The long list of board member assignments he has held includes those at Pharmacia & Upjohn, Skanska, Svenska Cellulosa Aktiebolaget, Industriförbundet and Svenskt Näringsliv. Nanologica customizes material properties to tackle issues pertaining solubility, stability and controlled release prevalent in the pharmaceutical and cosmetics sector, amongst others.
NanoMech, an international material science company announced that the NanoBusiness Commercialization Association (NanoBCA) has selected it for the 2012 Top Emerging Nano Innovators Award. "We are very proud of this recognition," said Jim Phillips, NanoMech Chairman and CEO. "The breakthrough technologies the NanoMech team has developed, such as nGlide®, TuffTek® , and TriboTuff® ,have led to this tremendous honor for our family of loyal employees and very supportive investors. NanoMech is focused on innovating by applying breakthrough novel science into "must-have" products bringing immediate and drastic improvement into existing major markets."
The NanoBCA is the industry’s top trade organization dedicated to promoting the advancement and commercialization of nanotechnology while helping companies bring affordable, life-improving nanotech products to the market. NanoMech also announced a partnership with KDH Defense Systems, Inc. to deploy technology that will keep soldiers and law enforcement professionals healthier and more comfortable through KDH’s award winning body armor.
Nanosphere, Inc., (NASDAQ: NSPH) announced the appointment of Roy N. Davis to the Board of Directors. Mr. Davis had been with Johnson & Johnson for nearly three decades prior to his retirement this past January. Moreover, Nanosphere‘s Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) (IUO), based on the company‘s proprietary array-based nanoparticle technology, demonstrated overall sensitivity and specificity of 99%, respectively, for the detection of a broad panel of gram-positive bacteria from positive blood cultures, according to a recent study. The BC-GP Test also correctly detected the presence or absence of genes encoding vancomycin resistance in Enterococcus spp. and methicillin resistance in Staphylococcus aureus or S. epidermidis.